Acute Myelogenous Leukemia (AML) Clinical Trials

Scottsdale : Call for Information (Investigational Site 0004)

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Duarte : City of Hope

A Phase 1 Study of AC220 (ASP2689) as Maintenance Therapy in Subjects with Acute Myeloid Leukemia Who Have Been Treated with an Allogeneic Hematopoietic Stem Cell Transplant

Duarte : City of Hope

A Phase I Study of 5-Fluoro-2-deoxycytidine with Tetrahydrouridine (FdCyd + THU) in Myeloid Leukemia and MDS

Duarte : City of Hope

A Randomized, Prospective, Double Blind, Placebo-Controlled, Phase 3 Study of US-ATG-F Prophylaxis as a Supplement to Standard of Care Prophylaxis to Prevent Moderate to Severe Chronic GVHD in Adult Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome Patients after Allogeneic Stem Cell Transplantation from Unrelated Donors

Duarte : City of Hope

COG AAML1031: A Phase III Randomized Trial for Patients with de novo AML Using Bortezomib and Sorafenib (IND# 114480; NSC#681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD

Duarte : City of Hope

FLT3 Mutation Diagnostic Assay Development Study

Duarte : City of Hope

Multi-Center Single Arm Phase II Study of Myeloablative Allogeneic Stem Cell Transplantation for Non-Remission Acute Myeloblastic Leukemia (AML) using Clofarabine and Busulfan X 4 (CloBu4) Regimen

Tampa : Call for Information (Investigational Site 0006)

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Savannah : Memorial University Medical Center

AAML1031, A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443) and Sorafenib (IND# 69896) for Patients with High Allelic Ratio FLT3/ITD

Baltimore : Call for Information (Investigational Site 0001)

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Houston : Call for Information (Investigational Site 0002)

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)

Morgantown : West Virginia University - Clinical Trials Research Unit

BMTCTN0901: A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

VOS-AML-301: A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (VALOR)

Kirkland : Merck Frosst Canada Ltd.

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)